Background Molecular tests for detection of human papillomaviruses (HPVs) play a crucial role in the prevention of cervical cancer, including recently announced elimination efforts …
PE Castle, MH Stoler, TC Wright, A Sharma… - The lancet …, 2011 - thelancet.com
Background The ATHENA study was designed to assess the performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping compared with liquid …
Commercial molecular tests for human papillomaviruses (HPV) are invaluable diagnostic tools in cervical carcinoma screening and management of women with cervical …
PURPOSE: To examine sexual orientation group disparities in the Papanicolaou (Pap) and sexually transmitted infection (STI)/human papillomavirus (HPV) tests among adolescents …
Testing for high-risk types of alpha human papillomaviruses (HPV) is an invaluable part of clinical guidelines for cervical carcinoma screening, management and treatment. In this …
M Poljak, BJ Kocjan - Expert review of anti-infective therapy, 2010 - Taylor & Francis
Five main groups of commercial assays for the multiplex detection of alpha human papillomaviruses (HPVs) are currently available. DNA-based screening assays, which test …
Y Zhu, C Ren, L Yang, X Zhang, L Liu, Z Wang - BMC cancer, 2019 - Springer
Background Atypical squamous cell of undetermined significance (ASCUS) is a common cervical cytological diagnosis. At present, HPV DNA assay is used to triage these patients …
G Coquillard, B Palao, BK Patterson - Gynecologic oncology, 2011 - Elsevier
OBJECTIVES: Current methods for HPV screening rely on the detection of L1 DNA from high risk genotypes (HRHPV). These assays have very high negative predictive values (~ 99%) …
R Emmadi, JB Boonyaratanakornkit… - The Journal of Molecular …, 2011 - Elsevier
The superior sensitivity and specificity associated with the use of molecular assays has greatly improved the field of infectious disease diagnostics by providing clinicians with …